Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab

Membranous Nephropathy (MN) is an autoimmune disease associated with antibodies against podocyte proteins: M-type phospholipase A2 receptor (PLA2R1) or thrombospondin type-1 domain-containing 7A (THSD7A) in 70 and 3% of patients, respectively. Antibody titer is correlated with disease activity: risi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Boyer-Suavet, Sonia, Andreani, Marine, Lateb, Maël, Savenkoff, Benjamin, Brglez, Vesna, Benzaken, Sylvia, Bernard, Ghislaine, Nachman, Patrick H., Esnault, Vincent, Seitz-Polski, Barbara
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6970431/
https://ncbi.nlm.nih.gov/pubmed/31998325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.03069
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars